Trial Profile
A phase II trial of LGT 209 for preventions and treatment of sepsis
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 15 Sep 2016
Price :
$35
*
At a glance
- Drugs LGT 209 (Primary)
- Indications Sepsis
- Focus Therapeutic Use
- 15 Sep 2016 New trial record